SYS ONLINE
SUPPLEMENT_SCHOLAR
evidence · mechanism · dose
Experimental/CosmeticResearch peptide

SNAP-8

aka Acetyl Octapeptide-3

Extended SNAP-25 mimetic used in anti-wrinkle topical formulations.

Educational explainer of a research peptide. Profiles in this section deliberately omit clinical-trial citations, dosing protocols, and purchase links. Not FDA-approved as a supplement; not a recommendation to use.

Overview

SNAP-8 is an octapeptide elongation of Argireline with claims of improved efficacy on expression lines in cosmetic formulations.

Source
  • Synthesized for cosmetic use
Forms
  • Topical serum and cream

Mechanism of action

Inhibits SNARE complex assembly to reduce neurotransmitter release at facial neuromuscular junctions.

Pathways
  • · SNARE inhibition
  • · Acetylcholine release reduction

How it acts on the body

SNAP-8 extends the Argireline sequence in an attempt to improve its affinity for the SNARE complex. In manufacturer data the wrinkle depth reduction is larger than Argireline at the same concentration; independent data are sparse.

Like Argireline, it is a topical-only cosmetic tool and not a substitute for neuromodulator injections in someone seeking that level of effect.

Hormonal & endocrine impact

How this peptide is reported to shift specific hormones and signaling molecules. Directionality reflects research literature and preclinical models, not clinical prescribing data.

Projected hormonal trajectory
Illustrative curves derived from reported direction of effect. Not measured patient data.

Curves are schematic shapes (sigmoid for increases/decreases, damped oscillation for modulation/stabilization) anchored to a 100% baseline. They communicate direction and tempo of change reported in research literature — not absolute hormone concentrations.

Acetylcholine release (local)Decreases
Local NMJ effect with no systemic hormonal change.

Effects on the body

Decreases
Expression line depth with consistent application

Organ system effects

Skin

Local action at expression lines.

Endocrine

None.

Reported effects

Drawn from preclinical research, anecdote, and small-scale clinical observation. No evidence grades are assigned — most peptides on this page lack rigorous human trials.

  • Non-invasive
  • Stable in cosmetic formulations

Potential side effects

Common
  • · Mild local irritation
Rare
  • · Allergic reactions
Serious
  • · None documented

Drug interactions

No notable interactions reported.

Pairing context

Often combined with
  • Peptide complexes and retinoids
    Complementary mechanisms for aging skin.
Avoid combining with
  • Compromised skin barrier
    Increased irritation potential.
Important. Research peptides described here are not FDA-approved supplements. Supplement Scholar does not endorse, recommend, or link to any source for purchase. Consult a qualified clinician before considering any peptide therapy.